SCHEMBL3166463

SCHEMBL3166463

CC(=O)NCCNc1cc(NCCNC(=O)Cc2ccc(Br)cc2)nc(-c2ccccc2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.47
CNR2 P34972 1/20 0.47
CYP1A2 P05177 6/20 0.46
GPR119 Q8TDV5 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
ADORA2A P29274 2/20 0.44
ADORA1 P30542 2/20 0.44
KDM4E B2RXH2 2/20 0.44
GLA P06280 1/20 0.44
CYP3A4 P08684 5/20 0.43
CLK4 Q9HAZ1 4/20 0.43
ALDH1A1 P00352 2/20 0.43
ALOX15 P16050 2/20 0.43
HSD17B10 Q99714 2/20 0.43
MAPK1 P28482 1/20 0.43
TSHR P16473 3/20 0.42
CYP2D6 P10635 3/20 0.42
ADORA3 P0DMS8 1/20 0.42
CYP2C19 P33261 1/20 0.42
OPRM1 P35372 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3162245 0.92 ALDH1A1 (0.47) CYP1A2ADORA2AADORA1KDM4ECYP3A4
SCHEMBL3156387 0.92 ADORA2A (0.48) CYP1A2ADORA2AADORA1KDM4ECYP3A4
SCHEMBL3171179 0.90 KMT2A (0.50) CYP1A2L3MBTL1ADORA2AADORA1KDM4E
SCHEMBL3177073 0.90 CYP1A2 (0.47) CYP1A2GPR119L3MBTL1KDM4EGLA
SCHEMBL3169166 0.88 ALDH1A1 (0.49) CNR1CNR2CYP1A2ADORA2AADORA1
SCHEMBL3166238 0.88 ALDH1A1 (0.54) CYP1A2ADORA2ACYP3A4CLK4ALDH1A1
SCHEMBL3262586 0.86 ADORA2A (0.56) CNR1CNR2CYP1A2L3MBTL1ADORA2A
SCHEMBL3170639 0.85 KMT2A (0.48) CNR1CNR2CYP1A2ADORA2AADORA1
SCHEMBL3168745 0.85 ADORA2A (0.56) CYP1A2L3MBTL1ADORA2AADORA1KDM4E
SCHEMBL3163133 0.84 TP53 (0.49) CYP1A2L3MBTL1ADORA2AADORA1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed